(Q24200865)

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Iron chelation improves endothelial function in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Hemin induces an iron-dependent, oxidative injury to human neuron-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Synthetic and natural iron chelators: therapeutic potential and clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Activation of iron handling system within the gerbil hippocampus after cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Assessment of outcome after severe brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Relation between iron stores and non-insulin dependent diabetes in men: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Antiplatelet therapy for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

The role of iron neurotoxicity in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Use of the Barthel index and modified Rankin scale in acute stroke trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Thrombolysis for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, [...]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009280.PUB2